Activity

Cardiff Lexington Corporation (OTCQB: CDIX) has announced its successful uplisting to the OTCQB Venture Market, with trading commencing on Thursday, May 15, 2025. The company will continue to trade under its existing ticker symbol, CDIX.
This move follows a rigorous application and approval process, verifying that Cardiff Lexington meets the OTCQB’s listing qualifications. According to Alex Cunningham, CEO of Cardiff Lexington, the uplisting marks a significant milestone, underscoring the company’s dedication to transparency, growth, and shareholder value. He also noted the company’s progress in business expansion and capital structure streamlining, positioning it for a strong 2025.
About the OTCQB Venture Market:
The OTCQB Venture Market is operated by OTC Markets Group Inc. and is designed for entrepreneurial and early-stage U.S. and international companies. To be listed, companies must adhere to current financial reporting standards and complete an annual verification and management certification process. The SEC recognizes the OTCQB as an “established public market.”
Benefits of Uplisting to OTCQB:
Uplisting to the OTCQB can provide several advantages for companies, including:
* Enhanced Visibility: Increased exposure to a broader range of investors, including institutional investors, as the OTCQB generally has higher trading volumes and more analyst coverage than lower tiers of the OTC markets.
* Improved Credibility: The stricter reporting standards and verification process of the OTCQB can boost a company’s credibility and demonstrate a commitment to corporate governance and financial transparency.
* Increased Liquidity: The enhanced visibility and credibility can lead to greater trading activity and liquidity for the company’s stock, making it more attractive to potential buyers and sellers.
* Greater Access to Capital: A more liquid and visible stock can make it easier for companies to raise capital in the future.
About Cardiff Lexington Corporation:
Cardiff Lexington Corporation is a diversified healthcare holding company primarily focused on orthopedics, spine care, and pain management. The company operates in two segments: Healthcare and Real Estate, providing diagnostic and surgical services for skeletal system injuries and disorders. Cardiff Lexington aims to grow through strategic acquisitions of synergistic healthcare companies, emphasizing efficiency, affordability, and improved patient outcomes. The company is based in Las Vegas, Nevada.

Video courtesy of Eurex

Video courtesy of Eurex